Core Points - The company is focusing on divesting low-efficiency assets to enhance resource allocation and improve asset utilization efficiency by transferring 11.11% equity in Nanjing Tianshi Software Technology Co., Ltd. [1] - The board approved an increase in the internal loan limit to support the full subsidiary's transformation in the "big health" industry, raising the total limit to 25 million RMB [2][3] Group 1 - The board meeting was held on August 1, 2025, with all 9 directors present, and the meeting complied with relevant laws and regulations [1] - The decision to transfer equity was made to focus on core business development and improve asset utilization [1] - The internal loan authorization aims to support the subsidiary's funding needs during its transformation in the "big health" sector [2][3] Group 2 - The internal loan will be sourced from the company's own funds and is not expected to negatively impact the company's ongoing operations or financial status [3] - The internal loan interest rate will not be lower than the prevailing loan market quotation rate [2]
开开实业: 第十届董事会第二十七次会议决议公告